Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)-Reference-Cited by-同舟云学术

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)

Published:2024-08 Issue: Volume: Page:
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Goutaudier Valentin^ORCID,Danger Richard^ORCID,Catar Rusan Ali^ORCID,Racapé Maud,Philippe Aurélie^ORCID,Elias Michelle,Raynaud Marc,Aubert Olivier,Bouton Didier,Girardin François,Vicaut Éric,Yaiche Sarhan,Demotes Jacques,Heidecke Harald,Taupin Jean-Luc,Randoux-Lebrun Christine,Zaidan Mohamad,Papuchon Emmanuelle,Le Mai Hoa,Nguyen Thi-Van-Ha,Moreso Francesc,Berney Thierry,Villard Jean,Legendre Christophe,Dragun Duska,Papalois Vassilios,Potena Luciano,Giral Magali,Gourraud Pierre-Antoine,Brouard Sophie,Crespo Elena,Halleck Fabian,Budde Klemens^ORCID,Bestard Oriol,Loupy Alexandre,Lefaucheur Carmen

Funder

Horizon 2020

Publisher

Elsevier BV

Reference59 articles.

1. Exploring the complexity of death-censored kidney allograft failure;Mayrdorfer;J Am Soc Nephrol,2021

2. Review of the clinical and economic burden of antibody-mediated rejection in renal transplant recipients;Muduma;Adv Ther,2016

3. The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection;Loupy;Am J Transplant,2020

4. Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics;Loupy;Kidney Int,2022

5. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study;Bu;Kidney Int,2022